Literature DB >> 29415955

Associations of Tobacco Smoking with Impaired Endothelial Function: The Circulatory Risk in Communities Study (CIRCS).

Meishan Cui1, Renzhe Cui1, Keyang Liu1, Jia-Yi Dong1, Hironori Imano1, Mina Hayama-Terada2, Isao Muraki1, Masahiko Kiyama2, Takeo Okada2, Akihiko Kitamura2,3, Mitsumasa Umesawa4,5, Kazumasa Yamagishi5, Tetsuya Ohira6, Hiroyasu Iso1.   

Abstract

AIMS: Smoking impairs endothelial function as an acute effect. However, few population-based studies have examined the association between smoking status and endothelial function or the dose-response and duration-response association of smoking with endothelial function. We examined whether smoking habits were associated with impaired endothelial function depending on smoking dose and duration.
METHODS: We conducted a cross-sectional study of 910 men and women aged 30-79 years from 2013 to 2016. Statistical analyses of the data were conducted between 2016 and 2017. Endothelial function was assessed by brachial artery flow-mediated dilation (FMD) measurement. Low FMD was defined in two ways as the cutoff point based on the lowest quartile of %FMD (<5.1%) and median of %FMD (<6.8%), regarding as impaired endothelial function. We investigated the smoking status in terms of cigarettes consumed per day and the duration of smoking.
RESULTS: Heavy and chronic smokers were associated with a high prevalence of impaired endothelial function. Those associations did not change substantially after adjustment for other cardiovascular risk factors. Among all participants, the multivariable-adjusted ORs (95% CIs) of low FMD (<5.1%) with reference to never smokers were 2.23 (1.00-5.14) for current heavy smokers of ≥ 30 cigarettes per day, 1.83 (1.04-3.20) for heavy smokers of ≥ 40 pack-years, and 2.16 (1.15-4.06) for chronic smokers of ≥ 40 years. For low FMD (<6.8%) those values was 2.17 (1.01-5.05), 1.70 (1.01-2.86), and 1.98 (1.07-3.69), respectively.
CONCLUSIONS: Similar associations were observed among only men. Heavy or long-term tobacco smoking may induce impaired endothelial function.

Entities:  

Keywords:  Flow-mediated dilation; Impaired endothelial function; Smoking

Mesh:

Year:  2018        PMID: 29415955      PMCID: PMC6143782          DOI: 10.5551/jat.42150

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  31 in total

1.  Nitroglycerin-mediated vasodilatation of the brachial artery may predict long-term cardiovascular events irrespective of the presence of atherosclerotic disease.

Authors:  Daijirou Akamatsu; Akira Sato; Hitoshi Goto; Tetsuo Watanabe; Munetaka Hashimoto; Takuya Shimizu; Hirofumi Sugawara; Hiroko Sato; Yoshiyuki Nakano; Teiji Miura; Tsutomu Zukeran; Fukashi Serizawa; Yow Hamada; Ken Tsuchida; Ichiro Tsuji; Susumu Satomi
Journal:  J Atheroscler Thromb       Date:  2010-10-20       Impact factor: 4.928

Review 2.  Relevance of endothelial-haemostatic dysfunction in cigarette smoking.

Authors:  Rossella R Cacciola; Francesca Guarino; Riccardo Polosa
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

3.  Associations of central aortic pressure and brachial blood pressure with flow mediated dilatation in apparently healthy Japanese men: The Circulatory Risk in Communities Study (CIRCS).

Authors:  Keyang Liu; Renzhe Cui; Ehab S Eshak; Meishan Cui; Jia-Yi Dong; Masahiko Kiyama; Takeo Okada; Akihiko Kitamura; Mitsumasa Umesawa; Kazumasa Yamagishi; Hironori Imano; Tetsuya Ohira; Hiroyasu Iso
Journal:  Atherosclerosis       Date:  2017-02-27       Impact factor: 5.162

4.  Cigarette smoking and platelet adhesion.

Authors:  R M Pittilo; J M Clarke; D Harris; I J Mackie; P M Rowles; S J Machin; N Woolf
Journal:  Br J Haematol       Date:  1984-12       Impact factor: 6.998

5.  Endothelial Dysfunction is Associated with Occult Coronary Artery Disease Detected by Positron Emission Tomography.

Authors:  Ambar Kulshreshtha; Yan Zheng; Arshed A Quyyumi; Emir Veledar; John Votaw; Irina Uphoff; Douglas J Bremner; Jack Goldberg; Viola Vaccarino
Journal:  IJC Metab Endocr       Date:  2014-09-01

Review 6.  Systemic effects of smoking.

Authors:  Dilyara G Yanbaeva; Mieke A Dentener; Eva C Creutzberg; Geertjan Wesseling; Emiel F M Wouters
Journal:  Chest       Date:  2007-05       Impact factor: 9.410

7.  Regular cigarette smoking influences the transsulfuration pathway, endothelial function, and inflammation biomarkers in a sex-gender specific manner in healthy young humans.

Authors:  Ilaria Campesi; Ciriaco Carru; Angelo Zinellu; Stefano Occhioni; Manuela Sanna; Mario Palermo; Giancarlo Tonolo; Giuseppe Mercuro; Flavia Franconi
Journal:  Am J Transl Res       Date:  2013-08-15       Impact factor: 4.060

8.  Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study.

Authors:  Tatsuya Maruhashi; Junko Soga; Noritaka Fujimura; Naomi Idei; Shinsuke Mikami; Yumiko Iwamoto; Masato Kajikawa; Takeshi Matsumoto; Takayuki Hidaka; Yasuki Kihara; Kazuaki Chayama; Kensuke Noma; Ayumu Nakashima; Chikara Goto; Hirofumi Tomiyama; Bonpei Takase; Akira Yamashina; Yukihito Higashi
Journal:  Heart       Date:  2013-10-23       Impact factor: 5.994

Review 9.  Oxidative stress and accelerated vascular aging: implications for cigarette smoking.

Authors:  Anna Csiszar; Andrej Podlutsky; Michael S Wolin; Gyorgy Losonczy; Pal Pacher; Zoltan Ungvari
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

Review 10.  Prognostic Value of Flow-Mediated Vasodilation in Brachial Artery and Fingertip Artery for Cardiovascular Events: A Systematic Review and Meta-Analysis.

Authors:  Yasushi Matsuzawa; Taek-Geun Kwon; Ryan J Lennon; Lilach O Lerman; Amir Lerman
Journal:  J Am Heart Assoc       Date:  2015-11-13       Impact factor: 5.501

View more
  7 in total

Review 1.  Tobacco Smoke and Endothelial Dysfunction: Role of Aldehydes?

Authors:  Jordan Lynch; Lexiao Jin; Andre Richardson; Daniel J Conklin
Journal:  Curr Hypertens Rep       Date:  2020-08-28       Impact factor: 5.369

2.  Melatonin attenuates smoking-induced atherosclerosis by activating the Nrf2 pathway via NLRP3 inflammasomes in endothelial cells.

Authors:  Zhewei Zhao; Xuebin Wang; Rui Zhang; Baitao Ma; Shuai Niu; Xiao Di; Leng Ni; Changwei Liu
Journal:  Aging (Albany NY)       Date:  2021-04-04       Impact factor: 5.682

3.  Glycemic management is inversely related to skeletal muscle microvascular endothelial function in patients with type 2 diabetes.

Authors:  Joshua M Bock; William E Hughes; Kenichi Ueda; Andrew J Feider; Satoshi Hanada; Darren P Casey
Journal:  Physiol Rep       Date:  2021-03

Review 4.  Evidence for the Benefits of Melatonin in Cardiovascular Disease.

Authors:  Mohammad Tobeiha; Ameneh Jafari; Sara Fadaei; Seyed Mohammad Ali Mirazimi; Fatemeh Dashti; Atefeh Amiri; Haroon Khan; Zatollah Asemi; Russel J Reiter; Michael R Hamblin; Hamed Mirzaei
Journal:  Front Cardiovasc Med       Date:  2022-06-20

Review 5.  Endothelial dysfunction in COPD: a systematic review and meta-analysis of studies using different functional assessment methods.

Authors:  Marieta P Theodorakopoulou; Maria Eleni Alexandrou; Dimitra Rafailia Bakaloudi; Georgia Pitsiou; Ioannis Stanopoulos; Theodoros Kontakiotis; Afroditi K Boutou
Journal:  ERJ Open Res       Date:  2021-06-28

6.  The endothelial function biomarker soluble E-selectin is associated with nonalcoholic fatty liver disease.

Authors:  Nynke Simons; Mitchell Bijnen; Kristiaan A M Wouters; Sander S Rensen; Joline W J Beulens; Marleen M J van Greevenbroek; Leen M 't Hart; Jan Willem M Greve; Carla J H van der Kallen; Nicolaas C Schaper; Casper G Schalkwijk; Coen D A Stehouwer; Martijn C G J Brouwers
Journal:  Liver Int       Date:  2020-01-29       Impact factor: 5.828

7.  Relationship between Endothelial Dysfunction and Prevalence of Chronic Kidney Disease: The Circulatory Risk in Communities Study (CIRCS).

Authors:  Yuting Li; Renzhe Cui; Keyang Liu; Ehab S Eshak; Meishan Cui; Jiayi Dong; Hironori Imano; Isao Muraki; Masahiko Kiyama; Akihiko Kitamura; Takeo Okada; Kazumasa Yamagishi; Mitsumasa Umesawa; Tetsuya Ohira; Hiroyasu Iso
Journal:  J Atheroscler Thromb       Date:  2020-09-02       Impact factor: 4.928

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.